Loading...
Loading...
Among the 8 tracked institutional investors we monitor, TCRX (TScan Therapeutics, Inc.) is held with a combined value of $10.53M across 10,453,569 shares. The largest holder is BAKER BROS. ADVISORS LP with a position worth $2.81M (0.02% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 4 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$10.53M
Total Shares Held
10,453,569
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | $2.81M | 0.02% | - |
| 2 | VANGUARD GROUP INC | $2.48M | 0.00% | New |
| 3 | BlackRock, Inc. | $1.86M | 0.00% | -0.4% |
| 4 | MILLENNIUM MANAGEMENT LLC | $1.47M | 0.00% | +261.8% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $1.38M | 0.00% | +19.6% |
| 6 | CITADEL ADVISORS LLC | $321.60K | 0.00% | +95.5% |
| 7 | STATE STREET CORP | $209.39K | 0.00% | - |
| 8 | FMR LLC | $1.31K | 0.00% | +160.0% |
As of the latest SEC 13F filings, BAKER BROS. ADVISORS LP is the largest institutional holder of TCRX with a position worth $2.81M, representing 0.02% of their portfolio. In total, 8 institutional investors hold TCRX with a combined value of $10.53M.
In the most recent quarter, 1 fund opened a new position in TCRX. Additionally, 4 increased their holdings and 1 reduced their positions.
Institutional investors hold $10.53M worth of TCRX stock across 8 positions. The largest institutional holder is BAKER BROS. ADVISORS LP with $2.81M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TCRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TCRX positions.